In-workflow module combining daily patient telemetry with CYP2D6 pharmacokinetic dosing references. Structure the titration journey. Surface the science. Let the clinician decide.
Titrately bridges the gap between patient visits with structured telemetry and pharmacogenomic reference data.
Four daily controls — symptom severity, side effects, sleep quality, medication adherence — in under 60 seconds. No dashboard to maintain, no engagement gamification.
Dose steps plotted against symptom trend, side-effect flags, and adherence. The prescriber sees a converging picture, not a raw data dump.
Surfaces only patients who need attention — tolerability flags, adherence patterns, pending titration decisions — ranked by clinical urgency.
When a PGx-relevant drug meets a known phenotype, Titrately surfaces the CPIC dosing reference card. Presents the science. Never prescribes.
Surfaces inside the host platform via SMART-on-FHIR/OAuth2. The prescriber never leaves their primary workflow. One integration per host.
Lightweight note + dose change recording. Logs to the outcomes dataset. The prescriber writes the actual Rx in their own EHR.
Standard ADHD titration relies on sparse, retrospective patient self-reports across weeks. Titrately replaces the blind spot with objective, between-visit telemetry alongside validated CYP2D6 reference guidelines.
Reduced CYP2D6 activity leads to higher atomoxetine plasma exposure and slower clearance.
Track your journey in under 30 seconds. Share exact symptoms with your doctor so they can support you with confidence. No streaks, no pressure. Missing a day is fine.
Titrately stays on the non-device clinical decision support side of the FDA line by design.
No output contains "Reduce dose to X" or "Change to Y." Only: dosing literature references for this phenotype.
Every observation is framed as "telemetry ready for review" or "reference material for clinical judgment."
Every PK reference card links to the published CPIC guideline or PharmGKB annotation. The clinician can independently verify.
"PK dosing reference only. Not a treatment recommendation. Clinical decision rests with the prescriber." On every card, every time.
Titrately integrates directly into the clinical workflow, organizing frictionless daily symptom signals alongside established pharmacokinetic references.
Open Platform